Physicians' Academy for Cardiovascular Education
Meeting Impression | Contemporary management of a patient with heart failure and diabetes: Implications from recent trials

Meeting Impression | Contemporary management of a patient with heart failure and diabetes: Implications from recent trials

May 28, 2018 – Vienna, Austria

See below to download the Meeting Impression

This lunch symposium held during Heart Failure 2018 in Vienna, Austria, explored the role of diabetes treatment in the management of heart failure (HF), in light of recent findings that novel glucose-lowering drugs affect CV outcomes. Different classes of novel diabetes drugs were considered, along with their effects on HF in safety and outcome trials. Potential mechanisms underlying the observed effects are discussed, as well as how these drugs may be benefitted from in the management of patients with diabetes and HF.

Educational information

This is a summary of the PACE symposium entitled '

Contemporary management of a patient with heart failure and diabetes: Implications from recent trials', held during Heart Failure 2018 in Vienna, Austria.

During this Satellite Symposium, the role of diabetes treatment in the management of heart failure and novel interventions targeted to improve cardiovascular outcomes were discussed, addressing the following topics:

Faculty

Prof. Martin Cowie, MD – Imperial College London, United Kingdom: Current management of heart failure & T2DM

Prof. Naveed Sattar, MD – University of Glasgow, United Kingdom: Understanding the mechanisms of SGLT2 inhibition in heart failure and diabetes

Prof. Faiez Zannad, MD – CHU- Nancy University, France: Guidance from outcome trials: What are the clinical implications

Disclosures

The symposium was supported by an unrestricted educational grant from Boehringer Ingelheim/Lilly.

Download the Meeting Impression View lectures and slides of this symposium

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.